Silencing of Atp2b1 increases blood pressure through vasoconstriction

Journal of Hypertension

Volumn 31, Issue 8, 2013, Pages 1575-1583

  Shin, Young Bin ^a   Lim, Ji Eun ^a   Ji, Su Min ^a   Lee, Hyeon Ju ^a   Park, So Yon ^a   Hong, Kyung Won ^a   Lim, Mihwa ^b   McCarthy, Mark I ^c,d   Lee, Young Ho ^b   Oh, Bermseok ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

ATP2B1; blood pressure; siRNA; vasoconstriction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); PHENYLEPHRINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPE; GENE SILENCING; GENETIC ASSOCIATION; HEART REPOLARIZATION; HYPERTENSION; IN VIVO STUDY; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASOCONSTRICTION; VASODILATATION;

EID: 84880569950     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836189e9     Document Type: Article

References (40)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004; 44:398-404.
2. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
4. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, et al. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A 2009; 106:226-231.
5. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 2009; 18:2288-2296.
6. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009; 41:527-534.
7. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-676.
8. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41:677-687.
9. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, et al. Metaanalysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011; 43:531-538.
10. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478:103-109.
11. Takeuchi F, Isono M, Katsuya T, Yamamoto K, Yokota M, Sugiyama T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation 2010; 121:2302-2309.
12. Tabara Y, Kohara K, Kita Y, Hirawa N, Katsuya T, Ohkubo T, et al. Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project. Hypertension 2010; 56:973-980.
13. 2+; ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys 2008; 476:65-74.
14. Palmgren MG, Axelsen KB. Evolution of P-type ATPases. Biochim Biophys Acta 1998; 1365:37-45.
15. 2+; pumps. J Membr Biol 1991; 120:1-15.
16. Keeton TP, Burk SE, Shull GE. Alternative splicing of exons encoding the calmodulin-binding domains and C termini of plasma membrane Ca(2+;)-ATPase isoforms 1, 2, 3, and 4. J Biol Chem 1993; 268:2740-2748.
17. Stauffer TP, Hilfiker H, Carafoli E, Strehler EE. Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. J Biol Chem 1993; 268:25993-26003.
18. 2+;-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem 2004; 279:33742-33750.
19. Prasad V, Okunade GW, Miller ML, Shull GE. Phenotypes of SERCA and PMCA knockout mice. Biochem Biophys Res Commun 2004; 322:1192-1203.
20. Gros R, Afroze T, You XM, Kabir G, Van Wert R, Kalair W, et al. Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ Res 2003; 93:614-621.
21. Kobayashi Y, Hirawa N, Tabara Y, Muraoka H, Fujita M, Miyazaki N, et al. Mice lacking hypertension candidate gene ATP2B1 in vascular smooth muscle cells show significant blood pressure elevation. Hypertension 2012; 59:854-860.
22. Bolcato-Bellemin AL, Bonnet ME, Creusat G, Erbacher P, Behr JP. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci U S A 2007; 104:16050-16055.
23. Kim MY, Seo EJ, Lee DH, Kim EJ, Kim HS, Cho HY, et al. Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia. Cardiovasc Res 2010; 87:119-126.
24. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902; 28:220-231.
25. Hill MA, Davis MJ, Meininger GA, Potocnik SJ, Murphy TV. Arteriolar myogenic signalling mechanisms: Implications for local vascular function. Clin Hemorheol Microcirc 2006; 34:67-79.
26. Husain M, Jiang L, See V, Bein K, Simons M, Alper SL, et al. Regulation of vascular smooth muscle cell proliferation by plasma membrane Ca(2+;)-ATPase. Am J Physiol 1997; 272 (6 Pt 1):C1947-C1959.
27. Monteith GR, Kable EP, Chen S, Roufogalis BD. Plasma membrane calcium pump-mediated calcium efflux and bulk cytosolic free calcium in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto normotensives rats. J Hypertens 1996; 14:435-442.
28. 2+; pump isoform 1a. J Biol Chem 1996; 271:5536-5544.
29. 2+;-Mg2+;)ATPase. Biochem Biophys Res Commun 1977; 77:1203-1209.
30. 2+;-Mg2+; ATPase activator from human erythrocytes: its similarity to the activator of 3':5' - cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 1977; 77:1210-1216.
31. 2+;/ calmodulindependent membrane-associated kinase CASK. J Biol Chem 2003; 278:9778-9783.
32. Buch MH, Pickard A, Rodriguez A, Gillies S, Maass AH, Emerson M, et al. The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J Biol Chem 2005; 280:29479-29487.
33. 2+; pump. Cell Calcium 2008; 43:550-561.
34. Cartwright EJ, Oceandy D, Neyses L. Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflugers Arch 2009; 457:665-671.
35. Holton ML, Wang W, Emerson M, Neyses L, Armesilla AL. Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways. World J Biol Chem 2010; 1:201-208.
36. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008; 57:645-653.
37. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Bruning JC, et al. Inactivation of the Fto gene protects from obesity. Nature 2009; 458:894-898.
38. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466:714-719.
39. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011; 43:513-518.
40. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, et al. Nomenclature of voltage-gated calcium channels. Neuron 2000; 25:533-535.